QUEST FOR GROWTH
Business update 30 September 2023
PRESS RELEASE
26 October 2023 / 5.40 PM
The enclosed information constitutes regulated information as defined in the | Royal Decree |
of 14 November 2007 regarding the duties of issuers of financial instruments | which have been |
admitted for trading on a regulated market |
MANAGER'S
REPORT
VALUATION QUEST FOR GROWTH
Stock Price | Net asset value/share | ||||
30/09/2023 | 30/06/2023 | 31/12/2022 | |||
30/09/2023 | |||||
5.10 EUR | 7.41 EUR | 7.78 EUR | 7.93 EUR | ||
Number of shares | 18,733,961 | 18,733,961 | 18,199,212 | ||
Discount of the share price versus Net Asset Value: 3.13%
Source: Estimate by Capricorn Partners NV
Results
Quest for Growth closed the first nine months of its financial year with a net loss of €5.5 million. The return on equity capital was -3.83%, without taking into account the increase in the number of outstanding shares, amounting to around 2.9%. Quest for Growth's share price decreased by 15% over the first nine months of the year to a closing price of 5.10 euros on 30 September 2023. The discount of the share price in relation to the net asset value rose to 31.1% at the end of the quarter, compared to 24.3% at the end of 2022.
Market Environment
The European stock market index STOXX Europe 600 Net Return rose by 8.5% over the first nine months of 2023. The STOXX Europe Small 200 Net Return rose by 3.1% over the same period. Thus far, 2023 has had its ups and downs as far as the stock exchange is concerned. While the first quarter was still marked by problems in the banking sector and high volatility in equity markets, the bulls regained the upper hand in the second quarter. Fuelled by a technological breakthrough in artificial intelligence, the beginning of August saw both the S&P 500 in the United States and the STOXX Europe 600 reaching new heights for this year. And that's when market sentiment slowly began to turn. Investors once again had their sights on rising long-term interest rates across the world. In the US, the 10-year Treasury yield reached its highest level since the beginning of 2008. The 10-year bond yield in Germany is approaching 3%, a level not seen since mid-2011. Most companies are managing to keep profits at a high level. European Small and Mid Caps however did struggle so far in 2023 and have been underperforming considerably on the stock market since mid-2021 compared to larger and more liquid stocks. The investment climate for unquoted shares is very challenging, especially for those companies that need additional money.
Investments in quoted equities
The estimated gross performance of listed shares has been slightly negative over the last nine months. Exceptions to this in the portfolio thus far this year include: B&C Speakers (+33%), an Italian manufacturer of components for loudspeakers; the Liège-based Belgians from EVS Broadcasting Systems closing at 27% in positive territory; and the 'Danish' Belgians of Jensen Group posted a share price rise of just under 23%. All three companies went through an extremely difficult period during the 2020 and 2021 lockdowns. That said, during this exceptional period, all three were able to rely on a rock solid balance sheet, market leadership in a very specific niche and management with a strategic vision that looks beyond the next round of results reporting. It is these ingredients that form the basis for the strong results noted by these three companies over 2023.
The company posting the biggest drop was German Stratec (-45%), a manufacturer of medical diagnostics equipment. Stratec bore the brunt of the sharp drop in demand for Covid tests. Another German company, ABO Wind, developer of renewable energy projects, saw its share price fall by almost 32% this year, unlike the steep rise in its share prices in recent years. Austria-basedMayr-Melnhof(-13%) faced a drop in demand for its cardboard products, compounded by the fact that it failed to sufficiently charge on increases in the price of raw materials to its end customers.
During 2023, Quest for Growth bought one new position in SII (Société pour l'Informatique Industrielle). The company focuses on technology support and IT consultancy to companies in the aviation, telecoms and utilities sectors, for instance. In recent years, SII has achieved an above-average growth, mainly through geographic expansion in Eastern Europe. SII's founders are still on board and opt for a decentralised structure with a focus on local entrepreneurship to expand the business further. SII has a considerable net cash position and despite the strong growth, the share is valued low.
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 1 |
We said goodbye to a total of four companies. Gurit, SAP, Steico and Umicore. The Swiss company, Gurit, a supplier in the wind power sector, saw its profitability decline significantly over the past two years. After a few good years, Steico saw growth and profitability decline in the wake of increased competition for wood fibre insulation in the domestic market in Germany. We took advantage of a temporary rebound in its share price when Irish Kingspan took over a majority interest in Steico from its founder. Umicore witnessed a further drop in the price of precious metals, while investment pressure for its battery division is set to remain high for the foreseeable future.
Investments in venture and growth capital
The Liege-based company Miracor Medical, specialised in interventional cardiology, was unable to attract new investors. The company has halted the pre-marketing of its PiCSO device and let go some of its employees. The value of Miracor Medical was already fully written off at the end of the 2022 financial year.
After the acquisition of HalioDx in 2021, part of the escrow amount was received during the second quarter of 2023. The remaining part will be paid out later and is currently valued at a 10% discount.
Investments in venture and growth funds
Confo Therapeutics was able to conclude two successful agreements at the Capricorn Health-Tech Fund. Confo Therapeutics, which has developed a platform for the discovery of medicines focused on G-protein-linked receptors (GPCRs), announced a global licensing agreement with Eli Lilly to finance the further phases of the clinical development of a medicine for treating pain due to nerve damage. The company subsequently also announced a collaboration with the large Japanese pharma company Daiichi Sankyo for the development of medicines to combat neurological illnesses. For both agreements, Confo Therapeutics will receive an advance payment and milestone payments.
Following the 2017 sale of Ogeda to Astellas Pharma in the Capricorn Health Tech Fund, a potential milestone payment is still outstanding. Astellas Pharma has published that its application for a new drug for fezolinetant has been approved with the US FDA. As a result, the total amount of the milestone was released by Astellas Pharma into an escrow account. This escrow account will be released and paid out to Ogeda's former shareholders after one year. The valuation has been positively adjusted as a result.
During the second quarter of 2023, Capricorn Digital Growth Fund invested in the Belgian company VoxelSensors. The company is developing a revolutionary 3D perception system for fusing physical and digital worlds. Their Switching Pixels™ system is a revolutionary sensor architecture designed for laser beam scanning-based 3D perception and offers low latency at low power consumption, as is required for future extended reality applications.
During the third quarter of 2023, Capricorn Cleantech Fund, which is in liquidation, sold the last shares in Avantium, a Dutch company. This leaves the fund with one participating interest in FRX Innovations.
At Capricorn Sustainable Chemistry Fund, the German company Prolupin had insolvency proceedings initiated and has now been declared bankrupt. In the third quarter, the Dutch company Black Bear Carbon resorted to filing for suspension of payments.
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 2 |
EVOLUTION SHARE PRICE AND NET ASSET VALUE | PERFORMANCE PER SHARE IN QUOTED PORTFOLIO SINCE 31/12/2022 |
60%
50%
40%
30%
20%
10%
0%
-10%
-20%
40 | |||||||||||||||||||||||
30 | |||||||||||||||||||||||
20 | |||||||||||||||||||||||
10 | |||||||||||||||||||||||
0 | |||||||||||||||||||||||
-10 | % | ||||||||||||||||||||||
-20 | |||||||||||||||||||||||
-30 | |||||||||||||||||||||||
-40 | |||||||||||||||||||||||
-50 | |||||||||||||||||||||||
STRATEC SE | ABO WIND AG | MAYR-MELNHOF KARTON AG | ROCHE HOLDING AG- GENUSSCHEIN | SII* | NEXUS AG | THERMADOR GROUPE | KERRY GROUP PLC-A | FINANCIERE DE TUBIZE | QfG quoted (e) | EQUASENS | DATRON AG | CEWE STIFTUNG & CO KGAA | STOXX Europe Small 200 NR | MELEXIS NV | TKH GROUP NV-DUTCH CERT | STOXX Europe 600 NR | NEDAP N.V. | LEM HOLDING SA-REG | WOLTERS KLUWER | JENSEN-GROUP NV | BROADCAST EQUIPMENT S.A. | B&C SPEAKERS SPA | |
* sinds 2/2/23, dag van de eerste aankoop in Quest for Growth | EVS | ||||||||||||||||||||||
Bron: Bloomberg, Capricorn Partners | |||||||||||||||||||||||
QfG Quoted (e): estimate excluding costs and cash |
Simplified capital structure, increased number of ordinary shares and reduced rights for preference shares
The Extraordinary General Meeting of 30 March 2023 has made the following unanimous decisions:
- The preferred class of shares A and the preferred class of shares B are merged into one class of preference shares.
- Of the 1,000 existing preference shares, 500 will be divided into 535,249 ordinary shares and lose their rights as preference shares. As a result, 535,249 ordinary shares will be added without increasing capital, which means the intrinsic value of each ordinary share is diluted by 2.86%.
- These additional 535,249 ordinary shares are subject to a lock-up obligation. Every six months, 25% of the non-transferability will be eliminated so that the shares are fully marketable as from 30 March 2025.
- Another 500 preference shares remain which continue to be reserved as variable incentive for the active management and on which a purchase option rests to the benefit of the Managing Company.
- The 500 preference shares are entitled to propose two candidate directors of the board of directors of QfG.
- The surplus share of the dividend that is distributed to the preferred shareholders will no longer be calculated based on the share of the
net profit which exceeds the amount necessary to pay all shareholders a reimbursement which is equal to a nominal value of 6% on an annual basis, but will be calculated based on the share of the dividend which exceeds the amount necessary to pay the shareholders a reimbursement equal to a nominal value of 6% cumulative and recoverable for previous years in which there were insufficient or no dividend distributions; this is to be calculated from 1 January 2023.
7. The surplus preferential dividend entitlement is reduced from 20% to 10% so that the fraction of the surplus share of the dividend cred- ited of all shareholders is raised from 80% to 90%.
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 3 |
Financial assets breakdown at 30 September 2023
QUOTED EQUITIES | |||||||
Number of | Change since | In % of Net | |||||
Company | Market | shares | 31/12/2022 | Currency | Share Price | Valuation in € | Asset Value |
Cleantech | |||||||
ABO WIND | Deutsche Börse (Xetra) | 40,306 | -20,481 | € | 50.2000 | 2,023,361 | 1.46% |
FRX INNOVATION | TSXV (Canada) | 493,842 | 0 | CAD | 0.0400 | 13,885 | 0.01% |
JENSEN GROUP | Euronext Brussel | 135,876 | -17,000 | € | 32.0000 | 4,348,032 | 3.13% |
KERRY GROUP | Euronext Dublin | 44,250 | 2,750 | € | 79.1800 | 3,503,715 | 2.53% |
MAYR-MELNHOF KARTON | Deutsche Börse (Xetra) | 22,500 | 0 | € | 127.8000 | 2,875,500 | 2.07% |
THERMADOR | Euronext Parijs | 48,444 | 13,000 | € | 78.8000 | 3,817,387 | 2.75% |
16,581,880 | |||||||
Digital | |||||||
B&C SPEAKERS | Borsa Italiana | 165,004 | 0 | € | 16.1000 | 2,656,564 | 1.91% |
CEWE STIFTUNG | Deutsche Börse (Xetra) | 55,309 | -9,986 | € | 88.1000 | 4,872,723 | 3.51% |
DATRON | Deutsche Börse (Xetra) | 119,000 | 0 | € | 10.6000 | 1,261,400 | 0.91% |
EVS | Euronext Brussel | 195,327 | 61,702 | € | 26.8500 | 5,244,530 | 3.78% |
LEM HOLDING | SWX Swiss Exchange | 1,446 | 0 | CHF | 2.045.0000 | 3,058,300 | 2.20% |
MELEXIS | Euronext Brussel | 62,789 | 11,500 | € | 81.7000 | 5,129,861 | 3.70% |
NEDAP | Euronext Amsterdam | 78,148 | -15,000 | € | 58.4000 | 4,563,843 | 3.29% |
SII | Euronext Parijs | 70,746 | 70,746 | € | 46.9500 | 3,321,525 | 2.39% |
TKH GROUP | Euronext Amsterdam | 133,570 | 0 | € | 37.5200 | 5,011,546 | 3.61% |
WOLTERS KLUWER | Euronext Amsterdam | 39,000 | -11,000 | € | 114.6500 | 4,471,350 | 3.22% |
39,591,643 | |||||||
Health | |||||||
EQUASENS | Euronext Parijs | 71,330 | 4,000 | € | 72.9000 | 5,199,957 | 3.75% |
NEXUS | Deutsche Börse (Xetra) | 62,919 | 3,518 | € | 51.7000 | 3,252,912 | 2.34% |
ROCHE | SWX Swiss Exchange | 18,000 | 1,500 | CHF | 250.4500 | 4,662,426 | 3.36% |
STRATEC | Deutsche Börse (Xetra) | 36,003 | 6,000 | € | 44.2500 | 1,593,133 | 1.15% |
TUBIZE | Euronext Brussel | 72,588 | 8,000 | € | 68.1000 | 4,943,243 | 3.56% |
19,651,671 | |||||||
75,825,194 | 54.65% |
VENTURE AND GROWTH CAPITAL | ||||||||
Change since | In % of Net | |||||||
Equity | Sector | 31/12/2022 | Currency | Valuation in € | Asset Value | |||
DMC | Cleantech | $ | 1,623,560 | 1.17% | ||||
ECLECTICIQ | Digital | € | 1,839,685 | 1.33% | ||||
FINQUEST | Digital | $ | 1,887,861 | 1.36% | ||||
FRUITCORE ROBOTICS | Diversified | € | 2,000,327 | 1.44% | ||||
NGDATA | Digital | €106,000 | € | 1,214,933 | 0.88% | |||
QPINCH | Cleantech | € | 2,137,498 | 1.54% | ||||
REIN4CED | Cleantech | €520,057 | € | 1,128,932 | 0.81% | |||
SENSOLUS | Digital | € | 2,046,085 | 1.47% | ||||
13,878,880 | 10.00% | |||||||
Debt | Sector | |||||||
FINQUEST | Digital | $300,000 | $ | 283,179 | 0.20% | |||
283,179 | 0.20% | |||||||
Lei 19 | | 3000 Leuven | | Belgium | | T: +32 16 28 41 00 | www.questforgrowth.com | | quest@questforgrowth.com | 4 | |||
VENTURE AND GROWTH FUNDS
Change since 31/12/2022
Capricorn Partners
Currency
Last valuation | |
date | Valuation in € |
In % of Net Asset Value
CAPRICORN CLEANTECH FUND | Cleantech | -€837,500 | € | 30/09/2023 | 29,251 | 0,02% |
CAPRICORN DIGITAL GROWTH FUND | Digital | € | 30/09/2023 | 6,245,211 | 4,50% | |
CAPRICORN FUSION CHINA FUND | Diversified | €476,665 | € | 30/09/2023 | 2,827,508 | 2,04% |
CAPRICORN HEALTH-TECH FUND | Health | € | 30/09/2023 | 11,475,520 | 8,27% | |
CAPRICORN ICT ARKIV | Digital | € | 30/09/2023 | 5,328,402 | 3,84% | |
CAPRICORN SUSTAINABLE CHEMISTRY FUND | Cleantech | €1,600,000 | € | 30/09/2023 | 11,700,742 | 8,43% |
Third party funds
CARLYLE EUROPE TECHNOLOGY PARTNERS II | Diversified | -€98,113 | € | 31/03/2023 | 10,389 | 0,01% |
LIFE SCIENCES PARTNERS III | Health | € | 30/06/2023 | 144,000 | 0,10% | |
LIFE SCIENCES PARTNERS IV | Health | € | 30/06/2023 | 476,000 | 0,34% | |
38,237,024 | 27,56% |
PORTFOLIO OVERVIEW
Quoted equities
Venture & Growth capital
Venture & Growth capital Funds
Change in valuation in Venture and Growth capital
Financial Assets
Cash
Other net assets & liabilities
Net Assets Value
Net Assets Value per share (€)
Stock price (€)
Discount %
75,825,194 | 54.65% |
14,162,059 | 10.21% |
38,237,024 | 27.56% |
-1,164,734 | -0.84% |
127,059,543 | 91.58% |
10,806,269 | 7.79% |
869,427 | 0.63% |
138,735,239 | 100.00% |
7,41 | |
5,10 | |
-31.13% |
Cleantech | Venture & | Cash & other |
27% | growth capital | net assets & |
funds | liabilities | |
28% | 8% |
Health
25%
Diversified | Digital | Venture & | Quoted |
46% | |||
2% | growth capital | equities | |
9% | 55% |
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 5 |
PORTFOLIO COMPOSITION AND MARKET CAPITALISATION AT 30 SEPTEMBER 2023
€ 160,000,000 | 27.56% | ||||||||||||
€ 140,000,000 | |||||||||||||
€ 120,000,000 | |||||||||||||
€ 100,000,000 | 54.65% | 9.37% | |||||||||||
€ 80,000,000 | |||||||||||||
€ 60,000,000 | |||||||||||||
€ 40,000,000 | |||||||||||||
€ 20,000,000 | 8.42% | ||||||||||||
€ 0 | |||||||||||||
Cash + | Quoted Equities Venture & Growth | Venture & Growth | Market cap | ||||||||||
Other net assets | Capital | Funds |
TOTAL SHAREHOLDERS RETURN (SINCE 30 SEPTEMBER 2013)
RESULTS FROM 1 JANUARY 2013 UNTIL 30 SEPTEMBER 2023
PORTFOLIO DISTRIBUTION BY COUNTRY
United | |||||
Singapore | Canada | Kingdom | |||
Italy | 1.7% | 0.0% | 0.0% | ||
2.1% | US | ||||
1.3% | |||||
Belgium | |||||
Switzerland | |||||
49.8% | |||||
6.0% | |||||
Ireland | |||||
2.7% | |||||
France | |||||
9.6% | |||||
Netherlands | Germany | ||||
12.9% | 13.9% |
PORTFOLIO DISTRIBUTION BY CURRENCY
EUR | USD | |
2.74% | ||
91.56% | CAD | |
0.01% | ||
CHF | ||
5.70% |
160,000,000
140,000,000
120,000,000
100,000,000
80,000,000
60,000,000
40,000,000
20,000,000
-
7.9 %
17.4 %
12.43%
20.3%
14.02%
34.5 %
-0.3 % -18.35%
12.43%
-14.70%
-3.83%
(20,000,000)
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 6 |
Added value per share
(January - September 2023)
Added value per sector per share
NAV / Share
PORTFOLIO | OPERATING | ||
8.00 | REVENUES & EXPENSES | ||
7.75
7.50
7.25
7.00
NAV 31/12/2022 | Impact EGM 30/03/2023 | Digital | Cleantech | Health | Operating revenues | Operatiing expenses | NAV 30/09/2023 |
Added value per segment per share
NAV / Share
8.00
7.75
7.50
7.25
7.00
NAV 31/12/2022 | Impact EGM 30/03/2023 | Quoted Equities (including dividend) | Venture & Growth Capital | Venture & Growth Funds | Operating revenues | Operatiing expenses | NAV 30/09/2023 |
PROFILE
Quest for Growth is a privak/pricaf, a public alternative investment fund (AIF) with fixed capital under Belgian law, managed by Capricorn Partners NV, The diversified portfolio of Quest for Growth is mostly invested in growth companies listed on European stock exchanges, in venture & growth capital and in venture & growth funds, Quest for Growth focuses on innovative companies in areas such as digital, health and clean technologies, We have been listed on Euronext Brussels since 23 September 1998.
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 7 |
Condensed interim financial statements
CONDENSED BALANCE SHEET
In EUR
ASSETS
Cash and cash equivalents
Short term debt securities
Trade and other receivables
Dividends receivable
Financial assets
Financial assets at FVTPL - equity securities
Financial assets at FVTPL - debt securities
Other current assets
Total assets
LIABILITIES AND EQUITY
Share capital
Unavailable reserves
Accumulated result
Net result for the period
Total equity attributable to shareholders
Transfer agents
Current tax payable
Other liabilities
Total liabilities
Total equity and liabilities
30 September | 31 December |
2023 | 2022 |
10,805,709 | 6,177,462 |
00
552,649 1,050,834
659,273 563,083
126,776,368 | 136,042,102 |
283,179 | 468,595 |
11,771 | 7,210 |
139,088,949 | 144,309,287 |
147,072,900 | 147,072,900 |
0 21,918,727
-
2,803,948 106,290
5,533,710 -24,828,966
138,735,242 | 144,268,952 |
284,822 | 0 |
28,769 | 219 |
40,115 | 40,115 |
353,707 | 40,335 |
139,088,949 | 144,309,287 |
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 8 |
Condensed interim financial statements
CONDENSED STATEMENT OF PROFIT OR LOSS
In EUR
Net realised gains / (losses) on financial assets
Net unrealised gains / (losses) on financial assets
Dividends income
Interest income
Net realised foreign exchange gain / (loss)
Net unrealised foreign exchange gain / (loss)
Total revenues
Other operating income / (loss)
Total operating revenues
Fee Management Company
Custodian fees
Director's fees
Levy on investment funds
Other operating expenses
Total operating expenses
Profit / (Loss) from operating activities
Net finance expenses
Profit / (Loss) before income taxes
Withholding tax expenses
Other incomes taxes
Profit / (Loss) for the period
30 September | 30 September | |
2023 | 2022 | |
-6,417,130 | 6,250,510 | |
23,945 | -29,405,499 | |
1,952,552 | 1,838,382 | |
33,505 | -2,285 | |
-2,535 | 7,640 | |
4,431 | 8,038 | |
-4,405,232 | -21,303,213 | |
927,078 | 0 | |
-3,478,154 | -21,303,213 | |
-1,109,195 | -1,083,194 | |
-28,376 | -36,489 | |
-82,523 | -111,070 | |
-133,449 | -166,223 | |
-356,437 | -144,750 | |
-1,709,978 | -1,541,725 | |
-5,188,132 | -22,844,938 | |
-943 | -2,604 | |
-5,189,076 | -22,847,542 | |
-316,085 | -293,257 | |
-28,550 | -219 | |
-5,533,710 | -23,141,019 | |
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 9 |
SUPPLEMENTARY INFORMATION
Board of directors
Ms Brigitte de Vet-Veithen, chairman and independent director
Mr Paul Van Dun, independent director
Mr Jos Clijsters, independent director
Ms Véronique Léonard, independent director
Mr Philippe de Vicq de Cumptich, director
Prof. Regine Slagmulder, director
Dr Jos B. Peeters, director
Ms Sabine Vermassen, director
Audit committee
Executive officers
Management company
Statutory auditor
Depository bank
Incorporation
Official listing
Security number
Stock price
Mr Paul Van Dun, chairman
Prof. Regine Slagmulder
Ms Véronique Léonard
Mr Philippe de Vicq de Cumptich
Ms Sabine Vermassen
Capricorn Partners NV, Lei 19 box 1, B-3000 Leuven
PwC Bedrijfsrevisoren LTD, represented by Mr Gregory Joos, Culliganlaan 5, 1831 Diegem
BELFIUS BANK BELGIË, Karel Rogierplein 11, B-1000 Brussels
9 June 1998
23 September 1998 on Euronext Brussels
ISIN: BE0003730448
Bloomberg: QFG BB Equity
Reuters: QUFG,BR
Telekurs: 950524
Company reports
Estimated net asset value
quarterly, the annual report will be published in March 2024
published every first Thursday of the month on the website www.questforgrowth.com
Closed-end private equity funds, submitted to the Royal Decree of 10 July 2016 on alternative institutions for collective investment in unquoted and growth companies, are an investment instrument designed to offer individual investors a suitable framework in which to invest in venture and growth capital and venture and growth funds.
The privak is under the supervision of the Financial Services and Market Authority (FSMA) and is subject to specific investment rules and obligations as regards the distribution of dividends.
Investment rules
- 25% or more of the portfolio must be invested in venture and growth capital;
- 70% or more of the portfolio (qualified investments) must be invested in
- venture and growth capital;
- quoted growth companies with a market capitali- sation of less than 1.5 billion euros;
- other alternative investment funds with an invest- ment policy similar to that of the private equity fund.
A private equity fund may not invest more than 20% of its portfolio in a single undertaking.
Lei 19 | 3000 Leuven | Belgium | T: +32 16 28 41 00 | www.questforgrowth.com | quest@questforgrowth.com | 10 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Quest for Growth NV published this content on 26 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 October 2023 15:45:38 UTC.